EQT — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
1X is an AI and robotics company developing general-purpose humanoid robots for home and industrial use.
AI & Machine LearningConsumerHardwareRoboticsPalo Alto, US
Bernt Øyvind Børnich(CEO)Bernt Børnich(Founder)in
Co-investorsAlliance VCAlliance VentureSamsung NextSandwaterSkagerak CapitalSprettert+8 more
Adevinta operates a portfolio of online classifieds and digital marketplaces spanning consumer goods, mobility, real estate, holiday rentals, and jobs.
ConsumerE-commerceMarketplaces
Co-investorsGeneral AtlanticTCV
Bluebook provides AI agents that handle research, reconciliations, and month-end closing work for accounting firms, enabling each professional to manage a significantly larger client base and freeing time for strategic advisory work.
AI & Machine LearningEnterprise SoftwareFintechSan Francisco, US
Philip Andersson(Co-Founder & CEO)inFilip Stål(Founder)in
Co-investorsY CombinatorEQT Ventures
Noema Pharma develops a late-stage portfolio of oral small molecule therapeutics for people with neurological and related disorders, targeting both orphan and larger indications with significant unmet medical needs.
BiotechHealthtechMedical Devices
Ilise Lombardo(Chief Executive Officer)Volker Knappertz(Executive Vice President of Research & Development)Michael Samar(Chief Financial Officer)Rob Lasser(Chief Medical Officer)
Co-investorsBioMedPartnersJeito CapitalRoche Venture FundSofinnova PartnersEQT Life SciencesForbion+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.